期刊文献+

江苏汉族正常人群NQO1基因常见位点多态性 被引量:5

COMMON SITES POLYMORPHISMS OF NQO1 GENE IN JIANGSU HAN NORMAL POPULATION
在线阅读 下载PDF
导出
摘要 [目的]探讨NQO1基因7个常见位点在江苏汉族人群中的多态性分布。[方法]应用聚合酶链式反应-限制性片断长度多态性(PCR-RFPL)、等位基因特异性引物-聚合酶链反应技术(AS-PCR)及普通Taqman探针等技术方法,对658例正常体检样本NQO1基因多位点进行分析。[结果]NQO1基因相关位点野生型纯合子、杂合子、突变纯合子3种基因型的分布频率分别是:rs1800566 44.8%,36.4%,18.8%;rs4986998 93.5%,6.2%,0.3%;rs10517 16.1%,60.1%,23.8%;编码区rs11555215和非编码区rs1050873,rs1063556,rs80564684个位点未检测到杂合子和突变纯合子。[结论]本研究结果与国内外相关报道有一定的差异。对了解不同种族、不同地域人群NQO1基因的遗传特征具有一定的参考价值。 [ Objective] To investigate the polymorphisms of NQO1 genes in Jiangsu ban population. [ Methods] PCRRFPL, AS-PCR and Taqman probe technique was used to perform genotyping. [Results] The genotyp results of 658 individuals showed that the population distribution frequency of related sites genotypes of wild type, heterozygote, homozygous variant were rs1800566 44.8%, 36.4%, 18.8%; rs4986998 93.5%, 6.2%, 0.3%; rs10517 16.1%, 60.1%, 23.8% respectively. Heterozygote and homozygous variant were not detected in another four sites. [ Conclusion ] These results differ from those of abroad and domestic among other population. It is significant to discuss genetic characteristics of NQO1 in different races and areas.
出处 《现代预防医学》 CAS 北大核心 2007年第5期835-838,共4页 Modern Preventive Medicine
基金 国家自然科学基金资助项目(30571540 30671732)
关键词 汉族人群 NQO1基因 多态性 Han population NQO1 Genetic polymorphism
  • 相关文献

参考文献14

二级参考文献21

  • 1[1]Jaiswal AK, McBride OW, Adesnik M, et al. Human dioxininducible cytosolic NAD(P)H: menadione oxidoreductase. cDNA sequence and localization of gene to chromosome 16[J]. J Biol Chem, 1988, 263(27): 13572~13578
  • 2[2]Tvaver RD, Horikosh T, Danenberg KD, et al. NAD(P)H:quinone oxidoreductase gene expression in human colon carcinoma cells: characterization of a mutation which modulates DT-diaphorase activity and mitomycin sensitivity [J]. Cancer Res, 1992, 52(4): 797~802
  • 3[3]Monks TJ, Hanzlik RP, Cohen GM, et al. Quinone chemistry and toxicity[J]. Toxicol Appl Pharmacol, 1992, 112(1): 2~16
  • 4[4]Siegel D, Anwar A, Winski SL, et al. Rapid polyubiquitination and proteasomal degradation of a mutant form of NAD (P)H:quinone oxidoreductase 1 [J]. Mol Pharmacol, 2001, 59(2):263 ~268
  • 5[5]Kuehl BL, Paterson JW, Peacock JW, et al. Presence of a heterozygous substitution and its relationship to DT-diaphorase activity[J]. Br J Cancer, 1995, 72(3): 555~561
  • 6[6]Kelsey KT, Ross D, Traver RD, et al. Ethnic variation in the prevalence of a common NAD (P)H quinone oxidoreductase polymorphism and its implications for anti-cancer chemotherapy[J]. BrJ Cancer, 1997, 76(7): 852~854
  • 7[7]Gaedigk A, Tyndale RF, Jurima-Romet M, et al. NAD(P)H:quinone oxidoreductase: polymorphisms and allele frequencies in Caucasian, Chinese and Canadian Native Indian and Inuit populations[J]. Pharmacogenetics, 1998, 8(4): 305~313
  • 8[8]Long DJ 2nd, Waikel RL, Wang XJ, et al. NAD (P)H:quinone oxidoreductase 1 deficiency and increased susceptibility to,12-dimethyl-benz [a]-anthracene induced carcinogenesis in mouse skin[J]. J Natl Cancer Inst, 2001, 93(15): 1166~1170
  • 9[9]Asher G, Lotem J, Cohen B, et al. Regulation of p53 stability and p53-dependent apoptosis by NADH quinoneoxidoreductase 1[J]. Proc Natl Acad Sci USA, 2001, 98(3): 1188~1193
  • 10[10]Asher G, Lotem J, Kama R, et al. NQO1 stabilizes p53through a distinct pathway[J]. Natl Acad Sci USA, 2002, 99(5): 3099~3104

共引文献25

同被引文献20

  • 1Benjaporn Buranrat,Auemduan Prawan,Upa Kukongviriyapan,Sarinya Kong-petch,Veerapol Kukongviriyapan.Dicoumarol enhances gemcitabine-induced cytotoxicity in high NQO1-expressing cholangiocarcinoma cells[J].World Journal of Gastroenterology,2010,16(19):2362-2370. 被引量:3
  • 2张文翠,尹立红,浦跃朴,梁戈玉,胡旭,刘耀珍,崔永生.NQO1基因ns-cSNP与淮安汉族人群食管癌易感性的关系[J].中华预防医学杂志,2006,40(5):324-327. 被引量:6
  • 3陈道俊,池煜,宇庆诚,王胜东,叶冬青.NQO1基因多态性与环境因素在胃癌发生中的交互作用[J].安徽医科大学学报,2007,42(4):405-409. 被引量:6
  • 4Pandith AA, Khan NP, Shah ZA, et al. Association of blad- der cancer risk with an NAD(P)H: quinone oxidoreductase polymorphism in an ethnic Kashmiri population[J]. Biochem Genet, 2011,49:417-426.
  • 5Wang Z, Hu J, Zhong J. Meta-analysis of the NAD(P)H: Quinine Oxidoreductase 1 Gene 609 C>T Polymorphism with Esophageal Cancer Risk[J]. DNA Cell Biol, 2012, 31: 560-567.
  • 6Begleiter A, Hewitt D, Maksymiuk AW, et al. A NAD(P) H:quinone oxidoreductase 1 polymorphism is a risk factor for human colon cancer [J]. Cancer Epidemiol Biomarkers Prey, 2006,15:2422-2426.
  • 7Kang SH, Kim TY, Kim HY, et al. Association of NQO1 polymorphism with multiple myeloma risk in Koreans [J]. Korean Lab Med, 2006,26:71-76.
  • 8Akkiz H, Bayram S, Bekar A, et al. No association of NAD (P) H: quinone oxidoreductase 1 (NQO1) C609T polymorphism and risk of hepatoeellular carcinoma development in Turkish[J]. Subjects Asian Pac Cancer Prey, 2010, 11: 1051-1058.
  • 9Chiu MM, Ko YJ, Tsou AP, et al. Analysis of NQO1 poly morphisms and p53 protein expression in patients with hepato- cellular carcinoma [J]. Histol Histopathol, 2009, 24: 1223-1232.
  • 10Das A, Dey N, Ghosh A, et al. NAD(P)H: quinone oxi doreductase 1 deficiency conjoint with marginal vitamin C deficiency causes cigarette smoke induced myelodysplastic syn- dromes[J]. PLoS One, 2011,6:e20590.

引证文献5

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部